Auxly Cannabis Group Stock Current Liabilities
| 3KF Stock | EUR 0.02 0.01 88.68% |
Auxly Cannabis Group fundamentals help investors to digest information that contributes to Auxly Cannabis' financial success or failures. It also enables traders to predict the movement of Auxly Stock. The fundamental analysis module provides a way to measure Auxly Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Auxly Cannabis stock.
Auxly |
Auxly Cannabis Group Company Current Liabilities Analysis
Auxly Cannabis' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Auxly Cannabis Group has a Current Liabilities of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Drug Manufacturers - Specialty & Generic industry. The current liabilities for all Germany stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Auxly Fundamentals
| Return On Equity | -35.01 | |||
| Return On Asset | -9.93 | |||
| Current Valuation | 321.75 M | |||
| Shares Outstanding | 565 M | |||
| Price To Earning | 20.65 X | |||
| Price To Book | 1.15 X | |||
| Price To Sales | 328.84 X | |||
| Revenue | 1.51 M | |||
| Gross Profit | 6.47 M | |||
| EBITDA | (12.93 M) | |||
| Net Income | (20.6 M) | |||
| Cash And Equivalents | 156.23 M | |||
| Cash Per Share | 0.37 X | |||
| Total Debt | 68.94 M | |||
| Debt To Equity | 29.30 % | |||
| Current Ratio | 9.36 X | |||
| Book Value Per Share | 0.49 X | |||
| Cash Flow From Operations | (13.7 M) | |||
| Earnings Per Share | (0.07) X | |||
| Beta | 7.93 | |||
| Market Capitalization | 347.95 M | |||
| Z Score | 3.0 |
About Auxly Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Auxly Cannabis Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Auxly Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Auxly Cannabis Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Auxly Stock
Auxly Cannabis financial ratios help investors to determine whether Auxly Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.